Home › Funds › Robinhood Asset Management, LLC › NBIX

Robinhood Asset Management, LLC position in NBIX

NEUROCRINE BIOSCIENCES INC · Health Care

Robinhood Asset Management, LLC reported holding 60,484 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$10.2M, representing 0.55% of its reported portfolio and ranking #47 among its reported holdings. Robinhood Asset Management, LLC has disclosed NBIX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)60.48K sh
Reported value held$10.19M
Portfolio Weight0.55%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Robinhood Asset Management, LLC's NBIX position evolved

Robinhood Asset Management, LLC first disclosed a stake in NBIX in Q4 2025 at 40,296 shares (US$5.7M). The position peaked in Q2 2026 at 60,484 shares, worth US$10.2M. Across 3 filings, Robinhood Asset Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 60,484 shares valued at US$10.2M — an increase of 2,400 shares quarter over quarter.. Notable position changes include a 44% increase in Q1 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 40.30K $5.72M New
Q1 2026 58.08K $7.65M Add
Q2 2026 60.48K $10.19M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NBIX and 13F data

NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 34 other funds we track also report a position in NBIX — the largest reported positions include Renaissance Technologies (US$393.7M), Two Sigma Investments (US$349.9M), Vestal Point Capital, LP (US$316.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NBIX

All NBIX fund holders →

FAQ

How long has Robinhood Asset Management, LLC held NBIX?

Robinhood Asset Management, LLC has disclosed NBIX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Robinhood Asset Management, LLC's current position in NBIX?

As of Q2 2026, Robinhood Asset Management, LLC holds 60.48K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $10.19M, representing 0.55% of its reported portfolio and ranking #47.

Has Robinhood Asset Management, LLC been buying or selling NBIX?

In the latest 13F filing (Q2 2026), Robinhood Asset Management, LLC increased its position in NBIX. The position peaked in Q2 2026 at 60.48K shares.

Which other funds hold NBIX?

Other major institutional holders of NBIX include Renaissance Technologies, Two Sigma Investments, Vestal Point Capital, LP, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.